trending Market Intelligence /marketintelligence/en/news-insights/trending/7Wz92t_vC1VweCsRTiHo9g2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us
In This List

ICC International Cannabis to acquire nearly half of Wayland's global portfolio

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

ICC International Cannabis to acquire nearly half of Wayland's global portfolio

Canada's ICC International Cannabis Corp. plans to acquire 49.9% of Wayland Group Corp.'s global assets and license portfolio.

ICC, a Vancouver, British Columbia-based producer of cannabidiol extracts for medical use, entered into a letter of intent to acquire Wayland's international assets and licenses, which will be held in a subsidiary owned by both parties. ICC and Wayland have until March 1, to complete a definitive purchase agreement.

Ontario-based Wayland, a medical cannabis producer, will receive 300 million ICC shares at a deemed price of 43 U.S. cents each, valuing Wayland's international business at about US$258 million.

The target portfolio will include licenses, applications and/or operations in Argentina, Australia, Colombia, Germany, Italy, Malta, Switzerland and the U.K. Wayland's European operations teams will be integrated into the international unit, which will also include key management from Wayland.

"This is a watershed acquisition for International Cannabis; adding cannabis operations in a variety of high profile jurisdictions, all while increasing exposure to high growth marketplaces including Germany and the Asia Pacific theater," Eugene Beukman, CEO and a director of International Cannabis, said.

The deal is subject to certain conditions, including regulatory, stock exchange and shareholder approvals.